COMMUNIQUÉS West-GlobeNewswire

EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
31/10/2024
WATERTOWN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with [...]
Nearly 350 Patients Participate in the Foundation for Sarcoidosis Research Externally Led Patient-Focused Drug Development Meeting with the FDA
31/10/2024
CHICAGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- On October 28, 2024, the Foundation for Sarcoidosis Research (FSR) hosted a groundbreaking Externally Led Patient-Focused Drug Development (EL-PFDD) meeting on sarcoidosis with [...]
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
31/10/2024
WOBURN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a [...]
HWH International Announces its Upcoming Launch of the Hapi Wealth Program
31/10/2024
Bethesda, MD, Oct. 31, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH” or the “Company”) (Nasdaq: HWH) is pleased to announce that the Company has scheduled the launch of Hapi Wealth, a program dedicated to [...]
Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak
31/10/2024
Photo caption: Rwanda Minister of State for Health, Yvan Butera, was among those who received Sabin’s investigational vaccine in the open-label clinical trial. WASHINGTON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- In continued [...]
KFSHRC Leads Ethical Integration of AI in Healthcare
31/10/2024
RIYADH, Saudi Arabia, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Responsible integration has become imperative as Artificial Intelligence (AI) continue to reshape the medical landscape. King Faisal Specialist Hospital & [...]
GUERBET : Financial agenda for 2025
31/10/2024
Financial agenda for 2025 Villepinte, 31 October 2024 : Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2025. Publications [...]
GUERBET : Calendrier financier de l'exercice 2025
31/10/2024
Calendrier financier de l’exercice 2025 Villepinte, le 31 octobre 2024 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, publie son calendrier financier [...]
Monica Lewinsky Visits Agnivesh Agarwal’s Primeks Medical, Advocates Against Cyberbullying in Istanbul
31/10/2024
The internationally recognized cyberbullying activist partners with Primeks Medical in Istanbul during National Cybersecurity Awareness Month, bringing attention to critical social issues and supporting Turkey’s growing [...]
Director/PDMR Shareholding
31/10/2024
DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support [...]
Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs
31/10/2024
Current timeline for drug development is 10-12 years and costs approximately $1-3 billion. Tevogen’s approach has the potential to shorten timelines and substantially reduce costs. Tevogen’s AI initiative, Tevogen.AI , [...]
Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)
31/10/2024
First Phase 3 PDT study in patients with sBCC in the United States. Primary and secondary endpoints all highly statistically significant p<0.0001 Correlates to data seen in Europe where sBCC is already incorporated [...]
AMN Healthcare Names Tomya Watt as Chief People Officer
31/10/2024
DALLAS, Oct. 31, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, today announced the appointment of Tomya Watt as Chief People [...]
Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain
31/10/2024
Company describes new biomarker and cognitive treatment effects that support continued development of pepinemab in Mild Cognitive Impairment and Mild Dementia due to Alzheimer’s disease ROCHESTER, N.Y., Oct. 31, 2024 ( [...]
Hormonic Unveils All-in-One Platform to Revolutionize Women’s Hormonal Health
31/10/2024
Hormonic offers personalized hormone health care through telehealth services and high-quality natural supplements, targeting root causes of imbalances Munich, Germany, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Hormonic is proud [...]
WAKE RADIOLOGY TO HOST LUNG CANCER SCREENING EVENT SATURDAY, NOVEMBER 9
31/10/2024
Raleigh, N.C., Oct. 31, 2024 (GLOBE NEWSWIRE) -- On Saturday, November 9, Wake Radiology UNC Health Rex, in partnership with the American College of Radiology, is participating in National Lung Cancer Screening Day, [...]
Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs
31/10/2024
PsyLabs develops and produces certified pharmaceutical-grade nature-derived psychedelics for applications in mental health and well-being Psyence Biomedical has issued common shares to Psyence Group pursuant to a debt- [...]
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024
31/10/2024
Society of Immunotherapy of Cancer (SITC) poster to be presented by collaborator from Memorial Sloan Kettering Cancer Center, Dr. Alan Ho, on November 9, 2024 NEW YORK and VIENNA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- [...]
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates
31/10/2024
FORT WORTH, TX, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused [...]

Pages